Economic models of hepatitis A virus immunization [4] (multiple letters)

Hepatology

Volumn 30, Issue 1, 1999, Pages 343-345

  Meltzer, M ^a   Messonnier, M L ^a   O'Connor, J B ^a   Imperiale, T F ^a   Singer, M E ^a   Das, A ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS VACCINE; LIVE VACCINE; INACTIVATED VACCINE;

CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; GROUPS BY AGE; HEALTH CARE COST; HEALTH STATUS; HEPATITIS A; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFECTION RATE; LETTER; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; COHORT ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; INCIDENCE; INFANT; LIFE EXPECTANCY; NOTE; STATISTICAL MODEL; VACCINATION; ADULT; MIDDLE AGED; QUALITY OF LIFE;

COHORT STUDIES; COST-BENEFIT ANALYSIS; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; INCIDENCE; INFANT; LIFE EXPECTANCY; MODELS, ECONOMIC; VACCINATION; VACCINES, ATTENUATED; VIRAL HEPATITIS VACCINES; ADULT; MIDDLE AGED; QUALITY OF LIFE; VACCINES, INACTIVATED;

EID: 0033037481     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300129     Document Type: Letter

References (0)